One Health Group plc (LON:OHGR), an independent provider of NHS-funded medical procedures, for patients referred through ‘Patient Choice’ for treatment in Orthopaedics, Spine, General Surgery, Gynaecology and Urology, has announced its audited results for the year ended 31 March 2025.
Financial Highlights
| • | Turnover of £28.4 million (FY24: £23.0 million) an organic increase of 23%. |
| • | Underlying EBITDA £2.02 million (FY24: £1.52 million) an increase of 33%. |
| • | Underlying adjusted earnings per share of 13.75 pence (FY24: 7.42 pence) an increase of 185%. |
| • | Following listing on AIM on 20 March and fundraise, year-end cash was £11.4 million (2024: £4.7 million) (including cash in the Employee Benefit Trust of £1.2 million) providing substantial resources for investment in growth, including funding of our first surgical hub. |
| • | Final dividend proposed of 4.13 pence per share, in line with the Board’s stated dividend policy. |
| • | Total dividend paid in respect of the year ended 31 March 2025 of 6.20 pence per share, with dividend cover of 2.2 times. |
| • | The Financial Statements are set out below and should be read in conjunction with the 2025 Annual Report which contains the notes to the Financial Statements. The Annual Report and Financial Statements 2025 can be viewed here: www.onehealth.co.uk/investors |
| • | Post period-end, trading in the first quarter has remained strong. |
Strategic Highlights: Surgical Hubs
| • | Contracts exchanged to purchase land in the North of England with a full planning application submitted in March 2025 for the construction of the first Surgical Hub which is expected to deliver significant additional operating capacity in 2026. Subject to planning approval, construction work is expected to commence in H1 2025/26. |
| • | Further locations are being explored for a second Surgical Hub and One Health continues to identify additional operating capacity in the independent sector to help deliver on Government Waiting List reduction targets. |
Operational Highlights
| • | The Group has maintained strong momentum over the year delivering new records in all operational KPIs. |
| • | 28% increase in new NHS patient referrals to 17,020 for the year (FY24:13,266). |
| • | Total patient consultations of 42,238 delivered, an increase of 25% (FY24: 33,695). |
| • | A total of 7,043 surgical procedures delivered for NHS patients (FY24: 6,169) a 14% increase, delivered through 9 independent hospitals. |
| • | 80 NHS Consultants provided their services to the Group over the year, an increase of 27% (FY24: 63). |
| • | Introduced Urology to the range of procedures provided to support a wider population of NHS patients. |
| • | Established 5-year contracts with the Group’s largest NHS commissioners representing approximately 70% of revenue, moving away from the historic annual renewal process and derisking future revenue streams. |
| • | Support provided to six NHS trusts over the year with internal waiting list reductions with NHS waiting list patient transfers representing 10% of full year revenue. |
| • | New agreement between the NHS and independent sector announced on 6 January 2025 to help tackle waiting lists and actively promote ‘greater patient choice’ with the NHS increasingly looking to independent providers for additional support. |
Commenting on trading and the outlook, Adam Binns, Chief Executive Officer, said:
“The whole team have delivered an exceptional year with multiple records established in key operational and financial measures across the organisation.
“In addition to a significant uplift in direct referrals from NHS patients exercising their statutory right to choose One Health as their provider of care through ‘Patient Choice’ after visiting their GP, we have continued to support five individual NHS Trusts’ with their internal patient waiting lists, further reducing the pressure on the NHS.
“Amongst several highlights in the year was a successful listing on AIM in March raising £7.8 million, with net proceeds to the Group of £5.6 million and £2.2 million gross proceeds to selling shareholders. This funding will be used to develop our first surgical hub, a key part of our mid to long term growth strategy to deliver strategic surgical capacity growth in underserved areas, with planning feedback expected shortly.
“We have delivered a strong performance in all our three drivers of growth; more patients, more operating theatre capacity and a record number of new surgeons applying to provide their services to the Group. This has enabled us to provide our services to a wider community of NHS patients.
“Finally, and importantly, key to our continued development is the investment in our people to ensure we continue to attract and retain the best talent, whilst focussing on nurturing and developing the expertise within the One Health team to support robust, clinically safe growth.
“Given the considerable progress made over the last year, One Health is well placed to support the increasing demands of NHS commissioners and NHS patients through the delivery of fast, free, local healthcare.
“Activity into Q1 26 has remained strong and we look forward to the future with confidence, as our business model which has been providing care, free at the point of delivery to NHS patients for over 20 years, continues to grow, providing more care to more patients through ‘Patient Choice’ across an ever-increasing geography to reduce the pressure on the NHS.”
Online investor presentation
Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer will provide an overview of the Company’s full-year financial results, key achievements and strategic outlook via a SparkLive Webcast at 15:30 BST today (Monday, 23 June 2025). The presentation will offer insights into One Health’s growth strategy and long-term vision, and will be followed by a live Q&A.
Please click on the link below to register for the webcast:
https://sparklive.lseg.com/ONEHEALTHGROUP/events/d0e32595-a4a2-4379-a646-7da97431a300/one-health-group-investor-event-and-full-year-results-announcement-for-2025
Participants will be able to submit questions using the ‘Ask a question’ button on the webcast page.
Notice of AGM
One Health announces that the 2025 Annual General Meeting (“AGM”) of the Company will be held at 131 Psalter Lane, Sheffield S11 8UX on Friday 12 September 2025 at 11:00 a.m.
Full details of the AGM (including how to participate in the AGM) and the resolutions that will be put to shareholders are set out in the Notice of AGM.
The Company’s Annual Report and Financial Statements 2025, Notice of AGM and Proxy Form have been posted today to all shareholders who have elected to receive printed copies. Electronic copies of these documents are available on the Company’s website: www.onehealth.co.uk/investors.
Dividend Timetable
The Company proposes to declare a final dividend of 4.13p per ordinary share in respect of the year ended 31 March 2025, subject to shareholder approval at the Company’s forthcoming AGM. The ex-dividend date for the final dividend is 4 September 2025, the record date is 5 September 2025 and the expected payment date is on or around 19 September 2025.
